Three experts, including Chantal Mathieu, MD, PhD, will explore the pros and cons of using metformin, glucagon-like peptide-1 receptor agonists, and sodium-glucose co-transporter 2 inhibitors in adult patients to help lower their insulin dosage and decrease the risks associated with type 1 diabetes during a Sunday morning symposium at the Scientific Sessions.

Pancreatic islet transplantation remains an experimental therapy for patients with type 1 diabetes, but studies continue to show promising results. Sunday afternoon during the Joint ADA/Diabetes UK Symposium, four researchers will offer a snapshot of where islet transplantation stands today and offer perspective on what must happen in the future to advance the therapy. Andrew…

During a virtual symposium at the Scientific Sessions, three experts discussed challenges faced by young adults with type 1 diabetes as they make the transition from childhood to adulthood. The panelists, including Anna Floreen Sabino, MSW, CDCES, emphasized the importance of strong support systems and access to helpful resources.

During a Saturday morning presentation at the Scientific Sessions, three culinary medicine researchers will demonstrate how clinicians can improve patient outcomes through nutrition. Chef Linda Shiue, MD, will discuss how to translate culinary medicine science into solutions for type 2 diabetes prevention and management.

An A1C value today has consequences for outcomes tomorrow. That’s the message John M. Lachin, ScD, will deliver during a Saturday morning symposium that will explore the long-term benefits of short-term tight glycemic management.

One of the most recent developments in diabetes research is the use of organoids, sometimes called “organs in a dish,” which are three-dimensional structures grown in a lab that mimic human organs in vivo. Four researchers, including Linda G. Griffith, PhD, will describe the current state and future potential of organoid and ‘physiomimetic’ research during…

A better understanding of the islets of Langerhans could lead to a new area of diabetes treatment, according to Barak Blum, PhD, one of three researchers who will provide an update on islet research during a Saturday afternoon symposium at the Virtual 80th Scientific Sessions.

Soon, many more individuals with monogenic diabetes will be properly recognized, diagnosed, and treated thanks to genetic research being conducted to improve personalized medicine for diabetes patients, according to Toni I. Pollin, MS, PhD, CGC. That research, along with other important genetic studies, will be discussed during a Saturday afternoon symposium.